TCL Archive Three Fourths Of Pediatric Patients are Getting Best Treatment; NCI Goal: Reach all The Others May 20, 1977
TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive Funding Opportunities: NCI Offers Funds To Develop, Validate Mouse Models November 20, 1998